These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond. Katz G; Arad M; Eldar M Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246 [TBL] [Abstract][Full Text] [Related]
6. Genetic characterization of familial CPVT after 30 years. Beery TA; Shah MJ; Benson DW Biol Res Nurs; 2009 Jul; 11(1):66-72. PubMed ID: 19398417 [TBL] [Abstract][Full Text] [Related]
7. A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations. de la Fuente S; Van Langen IM; Postma AV; Bikker H; Meijer A Pacing Clin Electrophysiol; 2008 Jul; 31(7):916-9. PubMed ID: 18684293 [TBL] [Abstract][Full Text] [Related]
8. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation. Allouis M; Probst V; Jaafar P; Schott JJ; Le Marec H Am J Cardiol; 2005 Mar; 95(5):700-2. PubMed ID: 15721128 [TBL] [Abstract][Full Text] [Related]
13. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia. Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848 [TBL] [Abstract][Full Text] [Related]
14. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia. Pflaumer A; Davis AM Heart Lung Circ; 2012 Feb; 21(2):96-100. PubMed ID: 22119737 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening. Haugaa KH; Leren IS; Berge KE; Bathen J; Loennechen JP; Anfinsen OG; Früh A; Edvardsen T; Kongsgård E; Leren TP; Amlie JP Europace; 2010 Mar; 12(3):417-23. PubMed ID: 20106799 [TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms. Laitinen PJ; Swan H; Kontula K Eur J Hum Genet; 2003 Nov; 11(11):888-91. PubMed ID: 14571276 [TBL] [Abstract][Full Text] [Related]
17. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report. Garabedian L; Verryckt A; Panzer J; De Wolf D Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993 [TBL] [Abstract][Full Text] [Related]
18. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report. Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature. Pott C; Dechering DG; Reinke F; Muszynski A; Zellerhoff S; Bittner A; Köbe J; Wasmer K; Schulze-Bahr E; Mönnig G; Kotthoff S; Eckardt L Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648 [TBL] [Abstract][Full Text] [Related]